David Stewart is a Gastroenterology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
297 Hillsdale Ave
Hillsdale, NJ 076422212
Telephone
201-666-2110Registry record last updated 20 Jun 2010.
Clinical trials
- Cimzia Versus Mesalamine for Crohn's Recurrence
Sponsor: Milton S. Hershey Medical Center
- Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Sponsor: National Cancer Institute (NCI)
- Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.2%Statin27.4%Simvastatin59%Atorvastatin Calcium41%Part D≥17 patientsCholesterol absorption inhibitor10.5%Ezetimibe100%Part D≥11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
15.7%Proton pump inhibitor8.5%Omeprazole100%Part D<11 patientsBiguanide (metformin)7.3%Metformin Hcl100%Part D<11 patientsGenitourinary & hormones
9.3%5-alpha Reductase Inhibitor9.3%Dutasteride52%Finasteride48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”